IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD)
Clinical trials for IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) explained in plain language.
Never miss a new study
Get alerted when new IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) trials appear
Sign up with your email to follow new studies for IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart failure drug showdown: which Beta-Blocker protects ICD patients best?
Disease control Recruiting nowThis study compares two common heart failure medications, carvedilol and metoprolol, in 2,000 adults who have an implantable cardioverter defibrillator (ICD). Participants currently taking metoprolol will be randomly assigned to either stay on it or switch to carvedilol. The goal…
Matched conditions: IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD)
Phase: PHASE4 • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 01, 2026 17:58 UTC
-
New online resource aims to ease worry for heart device patients
Knowledge-focused Recruiting nowThis study is creating and testing an online resource called CHOICE-ICD for people who have an implantable cardioverter defibrillator (ICD), a device that shocks the heart if it beats dangerously. The tool includes games, videos, and virtual reality to help patients and their fam…
Matched conditions: IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD)
Phase: NA • Sponsor: University of Ulster • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:03 UTC